WJA
CELG

Williams Jones & Associates’s Celgene Corp CELG Stock Holding History

Williams Jones & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.12M Sell
12,124
-628
-5% -$59.6K 0.02% 192
2019
Q1 		$1.2M Sell
12,752
-530
-4% -$46.4K 0.03% 184
2018
Q4 		$851K Buy
13,282
+2,679
+25% +$198K 0.02% 202
2018
Q3 		$949K Sell
10,603
-1,111
-9% -$98.2K 0.02% 236
2018
Q2 		$930K Sell
11,714
-2,160
-16% -$179K 0.02% 233
2018
Q1 		$1.24M Buy
13,874
+20
+0.1% +$1.92K 0.03% 211
2017
Q4 		$1.45M Sell
13,854
-8,874
-39% -$1M 0.03% 207
2017
Q3 		$3.31M Buy
22,728
+700
+3% +$95.3K 0.08% 148
2017
Q2 		$2.86M Sell
22,028
-1,406
-6% -$172K 0.07% 158
2017
Q1 		$2.92M Sell
23,434
-71,078
-75% -$8.51M 0.08% 158
2016
Q4 		$10.9M Sell
94,512
-95,300
-50% -$10.6M 0.31% 78
2016
Q3 		$19.8M Sell
189,812
-56,329
-23% -$6.1M 0.58% 56
2016
Q2 		$24.3M Sell
246,141
-53,333
-18% -$5.52M 0.75% 44
2016
Q1 		$30M Sell
299,474
-38,988
-12% -$4.01M 1.4% 20
2015
Q4 		$40.5M Sell
338,462
-44,571
-12% -$5.16M 1.85% 13
2015
Q3 		$41.4M Sell
383,033
-9,158
-2% -$1.14M 1.86% 14
2015
Q2 		$45.4M Buy
392,191
+25,252
+7% +$2.89M 1.74% 15
2015
Q1 		$42.3M Buy
366,939
+194,927
+113% +$23.3M 1.7% 12
2014
Q4 		$19.2M Buy
172,012
+37,760
+28% +$3.98M 0.79% 37
2014
Q3 		$12.7M Buy
134,252
+2,910
+2% +$263K 0.58% 52
2014
Q2 		$11.3M Sell
131,342
-167,302
-56% -$12.7M 0.51% 51
2014
Q1 		$20.8M Buy
298,644
+167,540
+128% +$13.3M 0.42% 64
2013
Q4 		$11.1M Buy
131,104
+121,504
+1,266% +$9.61M 0.53% 54
2013
Q3 		$740K Buy
9,600
+114
+1% +$7.99K 0.04% 168
2013
Q2 		$555K Buy
+9,486
New +$571K 0.03% 209

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Williams Jones & Associates's CELG Position: Q2 2019 in Review

Williams Jones & Associates reduced its Celgene Corp (CELG) stake by 4.9% in Q2 2019, selling an estimated $59.6K and leaving 12,124 shares worth $1.12M. The position accounts for 0.02% of the portfolio, ranked #192.

Williams Jones & Associates first reported a position in CELG in Q2 2013 and has held it in 25 quarters since. The position peaked at $45.4M in Q2 2015. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Williams Jones & Associates held 12,124 shares of Celgene Corp worth $1.12M as of Q2 2019.
  • Williams Jones & Associates sold 628 Celgene Corp shares in Q2 2019, an estimated $59.6K.
  • Celgene Corp made up 0.02% of Williams Jones & Associates's portfolio in Q2 2019, its #192 holding.
  • Williams Jones & Associates first reported a position in Celgene Corp in Q2 2013 and has held it in 25 quarters since.
  • Williams Jones & Associates's Celgene Corp position peaked at $45.4M in Q2 2015.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.